Lilly raises full-year earnings forecasts on surging demand for weight-loss drug – Reuters

  1. Lilly raises full-year earnings forecasts on surging demand for weight-loss drug  Reuters
  2. Lilly reports second-quarter 2025 financial results and raises guidance | Eli Lilly and Company  Eli Lilly
  3. Eli Lily Q2 Earnings Preview: Future Depends on Mounjaro and Zepbound Performance  Investing.com
  4. These 2 stocks are still on our shopping list, and what Eli Lilly needs to deliver on earnings  CNBC
  5. Eli Lilly beats earnings for second quarter on strong GLP-1 sales, but stock dives on GLP-1 pill trial results  Yahoo Finance

Continue Reading